Axilium Capital
Overview
Axilium Capital is a Swedish growth equity firm that invests in unlisted growth companies in sectors including artificial intelligence, blockchain, energy storage, robotics, and life science.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sigrid Therapeutics | Sep 2019 | VC Round | Co-investor |
| ResoTher Pharma | May 2021 | Private Placement | Co-investor |
| Sarcura | Nov 2020 | Seed | Co-investor |
Key People
Arash Jamali
Co-Founder
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Axilium Capital based?
Axilium Capital is headquartered in Gothenburg, United States.
When was Axilium Capital founded?
Axilium Capital was founded in 2018.
How many portfolio companies does Axilium Capital have?
Axilium Capital has 3 portfolio companies in Caplight's dataset.
What are some companies in Axilium Capital's portfolio?
Portfolio companies visible on Caplight include Sigrid Therapeutics, ResoTher Pharma, Sarcura.
What was Axilium Capital's most recent investment shown here?
Axilium Capital's most recent investment in this portfolio sample was in ResoTher Pharma in 2021.
What sectors does Axilium Capital focus on?
Axilium Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Axilium Capital focus on?
Stage focus information for Axilium Capital is not publicly available.